Analysis
Commure raised $70 million in a round led by General Catalyst -- with Sequoia Capital and Morgan Stanley participating -- at a roughly $7 billion valuation. The company builds AI tools and agents that embed directly in the workflows of health systems and providers, with a focus on revenue-cycle management and clinical administration: the paperwork-heavy back office that consumes close to $1 trillion a year across US healthcare.
Commure's platform now operates inside more than 500 healthcare organizations across 3,000-plus sites of care, embedded in the daily workflows of tens of thousands of physicians. That distribution is the moat. Selling AI into hospitals is brutally hard -- long sales cycles, compliance, integration with legacy EHRs -- and Commure has already cleared that gauntlet at scale, which is exactly why a $7 billion mark holds up on modest revenue.
“The round underscores where applied AI's real money is: not in horizontal chatbots, but in vertical agents that own an expensive, miserable workflow.”
The round underscores where applied AI's real money is: not in horizontal chatbots, but in vertical agents that own an expensive, miserable workflow. Administrative cost is the largest and least-automated line item in US healthcare, and General Catalyst -- which is also buying and operating hospitals directly -- is betting Commure becomes the operating layer underneath them.
